S02-36C26222Q1669_1.pdf

PAGE 1 OF1. REQUISITION NO.

2. CONTRACT NO. 3. AWARD/EFFECTIVE DATE 4. ORDER NO. 5. SOLICITATION NUMBER 6. SOLICITATION ISSUE DATE

a. NAME b. TELEPHONE NO. (No Collect Calls) 8. OFFER DUE DATE/LOCAL

TIME

9. ISSUED BY CODE 10. THIS ACQUISITION IS UNRESTRICTED OR SET ASIDE: % FOR:

SMALL BUSINESS

HUBZONE SMALL

BUSINESS

SERVICE-DISABLED

VETERAN-OWNED

SMALL BUSINESS

WOMEN-OWNED SMALL BUSINESS

(WOSB) ELIGIBLE UNDER THE WOMEN-OWNED

SMALL BUSINESS PROGRAM

EDWOSB

8(A)

NAICS:

SIZE STANDARD:

11. DELIVERY FOR FOB DESTINA-

TION UNLESS BLOCK IS

MARKED

SEE SCHEDULE

12. DISCOUNT TERMS

13a. THIS CONTRACT IS A

RATED ORDER UNDER

DPAS (15 CFR 700)

13b. RATING

14. METHOD OF SOLICITATION

RFQ IFB RFP

15. DELIVER TO CODE 16. ADMINISTERED BY CODE

17a. CONTRACTOR/OFFEROR CODE FACILITY CODE 18a. PAYMENT WILL BE MADE BY CODE

TELEPHONE NO. UEI: EFT:

PHONE: FAX:

17b. CHECK IF REMITTANCE IS DIFFERENT AND PUT SUCH ADDRESS IN OFFER

18b. SUBMIT INVOICES TO ADDRESS SHOWN IN BLOCK 18a UNLESS BLOCK BELOW IS CHECKED

SEE ADDENDUM

19. 20. 21. 22. 23. 24.

ITEM NO. SCHEDULE OF SUPPLIES/SERVICES QUANTITY UNIT UNIT PRICE AMOUNT

(Use Reverse and/or Attach Additional Sheets as Necessary)

25. ACCOUNTING AND APPROPRIATION DATA 26. TOTAL AWARD AMOUNT (For Govt. Use Only)

27a. SOLICITATION INCORPORATES BY REFERENCE FAR 52.212-1, 52.212-4. FAR 52.212-3 AND 52.212-5 ARE ATTACHED. ADDENDA ARE ARE NOT ATTACHED.

27b. CONTRACT/PURCHASE ORDER INCORPORATES BY REFERENCE FAR 52.212-4. FAR 52.212-5 IS ATTACHED. ADDENDA ARE ARE NOT ATTACHED

28. CONTRACTOR IS REQUIRED TO SIGN THIS DOCUMENT AND RETURN _______________ 29. AWARD OF CONTRACT: REF. ___________________________________ OFFER COPIES TO ISSUING OFFICE. CONTRACTOR AGREES TO FURNISH AND DATED ________________________________. YOUR OFFER ON SOLICITATION DELIVER ALL ITEMS SET FORTH OR OTHERWISE IDENTIFIED ABOVE AND ON ANY (BLOCK 5), INCLUDING ANY ADDITIONS OR CHANGES WHICH ARE ADDITIONAL SHEETS SUBJECT TO THE TERMS AND CONDITIONS SPECIFIED SET FORTH HEREIN IS ACCEPTED AS TO ITEMS:

30a. SIGNATURE OF OFFEROR/CONTRACTOR 31a. UNITED STATES OF AMERICA (SIGNATURE OF CONTRACTING OFFICER)

30b. NAME AND TITLE OF SIGNER (TYPE OR PRINT) 30c. DATE SIGNED 31b. NAME OF CONTRACTING OFFICER (TYPE OR PRINT) 31c. DATE SIGNED

AUTHORIZED FOR LOCAL REPRODUCTION (REV. NOV 2021)

PREVIOUS EDITION IS NOT USABLE Prescribed by GSA - FAR (48 CFR) 53.212

7. FOR SOLICITATION

INFORMATION CALL:

STANDARD FORM 1449

SOLICITATION/CONTRACT/ORDER FOR COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES

OFFEROR TO COMPLETE BLOCKS 12, 17, 23, 24, & 30

600-23-1-119-0004

36C26222Q1669 09-08-2022

Hestia Sim 562-766-2239 09-15-2022

10:00 AM PDT

36C262 Department of Veterans Affairs Network Contracting Office 22 4811 Airport Plaza Drive Suite 600 Long Beach CA 90815

X

325412

1250 Employees

N/A

X

Department of Veterans Affairs VA Long Beach Healthcare System

5901 East 7th Street Long Beach CA 90822

36C262

Department of Veterans Affairs Network Contracting Office 22 4811 Airport Plaza Drive Suite 600 Long Beach CA 90815

Department of Veterans Affairs Financial Services Center Submit invoices electronically through https://portal.tungsten-network.com

877-353-9791

See CONTINUATION Page

This solicitation is issued to purchase the compounded chemotherapy medications listed under B.2 Statement of Work for VA Long Beach Healthcare System.

All interested contractors MUST be able to provide entire list of compounded chemotherapy medications on an as needed basis and on the terms and conditions stated within the Statement of Work.

The period of performance is Oct 1, 2022 - Sep 30, 2023

See CONTINUATION Page

X X

X 1

Peter Kim Contracting Officer

36C26222Q1669

Table of Contents

SECTION A

A.1 SF 1449 SOLICITATION/CONTRACT/ORDER FOR COMMERCIAL PRODUCTS

AND COMMERCIAL SERVICES

SECTION B - CONTINUATION OF SF 1449 BLOCKS

B.1 CONTRACT ADMINISTRATION DATA

B.2 STATEMENT OF WORK

B.3 PRICE/COST SCHEDULE

ITEM INFORMATION

B.4 DELIVERY SCHEDULE

SECTION C - CONTRACT CLAUSES

C.1 52.212-4 CONTRACT TERMS AND CONDITIONS—COMMERCIAL PRODUCTS

AND COMMERCIAL SERVICES (NOV 2021)

C.2 52.212-5 CONTRACT TERMS AND CONDITIONS REQUIRED TO IMPLEMENT

STATUTES OR EXECUTIVE ORDERS—COMMERCIAL PRODUCTS AND

COMMERCIAL SERVICES (MAY 2022) (JUL 2020) (DEVIATION)

C.3 52.252-2 CLAUSES INCORPORATED BY REFERENCE (FEB 1998)

C.4 VAAR 852.211-72 TECHNICAL INDUSTRY STANDARDS (NOV 2018)

C.5 VAAR 852.212-70 PROVISIONS AND CLAUSES APPLICABLE TO VA

ACQUISITION OF COMMERCIAL ITEMS (APR 2020)

C.6 VAAR 852.219-75 SUBCONTRACTING COMMITMENTS MONITORING AND

COMPLIANCE (JUL 2018)

SECTION D - CONTRACT DOCUMENTS, EXHIBITS, OR ATTACHMENTS

SECTION E - SOLICITATION PROVISIONS

E.1 52.204-24 REPRESENTATION REGARDING CERTAIN TELECOMMUNICATIONS

AND VIDEO SURVEILLANCE SERVICES OR EQUIPMENT (NOV 2021)

E.2 52.209-7 INFORMATION REGARDING RESPONSIBILITY MATTERS (OCT 2018)

E.3 52.212-1 INSTRUCTIONS TO OFFERORS—COMMERCIAL PRODUCTS AND

COMMERCIAL SERVICES (NOV 2021)

E.4 52.212-2 EVALUATION—COMMERCIAL PRODUCTS AND COMMERCIAL

SERVICES (NOV 2021)

E.5 52.212-3 OFFEROR REPRESENTATIONS AND CERTIFICATIONS—

COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES (MAY 2022) (JUL 2020)

(DEVIATION)

E.6 52.216-1 TYPE OF CONTRACT (APR 1984)

E.7 52.252-1 SOLICITATION PROVISIONS INCORPORATED BY REFERENCE (FEB

1998)

E.8 52.233-2 SERVICE OF PROTEST (SEP 2006)

E.9 52.233-3 PROTEST AFTER AWARD (AUG 1996)

SECTION B - CONTINUATION OF SF 1449 BLOCKS

B.1 CONTRACT ADMINISTRATION DATA

1. Contract Administration: All contract administration matters will be handled by the following individuals:

a. CONTRACTOR:

b. GOVERNMENT: Contracting Officer 36C262

Department of Veterans Affairs

Network Contracting Office 22

4811 Airport Plaza Drive

Suite 600

Long Beach CA 90815

2. CONTRACTOR REMITTANCE ADDRESS: All payments by the Government to the contractor will be made in accordance with:

[X] 52.232-33, Payment by Electronic Funds Transfer—System For Award Management, or

[] 52.232-36, Payment by Third Party

3. INVOICES: Invoices shall be submitted in arrears:

a. Quarterly []

b. Semi-Annually []

c. Other [X] Upon Delivery and Acceptance

4. GOVERNMENT INVOICE ADDRESS: All Invoices from the contractor shall be submitted electronically in accordance with VAAR Clause 852.232-72 Electronic Submission of Payment Requests.

Submit invoices electronically through https://portal.tungsten-network.com

ACKNOWLEDGMENT OF AMENDMENTS: The offeror acknowledges receipt of amendments to the Solicitation numbered and dated as follows:

AMENDMENT NO DATE

B.2 STATEMENT OF WORK

The Department of Veterans Affairs (VA), VISN 22 Network Contracting Office, is seeking a vendor able to provide the manufacturing and delivery of compounded chemotherapy drugs from an FDA 503A compliant facility for the treatment of patients receiving services at the VA Long Beach Healthcare System.

All interested companies must be able to provide entire list of compounded chemotherapy medications on an as needed basis and on the terms and conditions stated below.

There will be approximately (30) thirty patients on any given day, Monday through Friday for chemotherapy infusion for 52 weeks. Below is a list of the common chemotherapy drugs will be provided directly to the vendor. Must be able to supply and deliver all compounded chemotherapy medications listed below. Orders are based on need for each patient. Please include the temperature logger in shipments to monitor temperature of drugs for quality assurance. Shipping fees must be inclusive (cost per week) within the hazardous compounded chemotherapy drug.

1. Requirement

1.1. The Vendor must be able to compound and provide the hazardous medications, including supportive medications, for the VA Long Beach Pharmacy; approximately thirty patients on any given day throughout the performance period. The medications required are included in, but not limited to, the list below.

1.2. All medications must be delivered with no less than 12 hours remaining on the Beyond-Use-Date (BUD) and no sooner than 6pm PST/PDT on the date of delivery to allow adequate time for the administration to clinic patients during their regularly scheduled appointments.

1.3. Vendor must have a certified 503A pharmacy(s) with an active board of pharmacy license that are licensed to ship into/within the State of California.

1.4. The vendor must complete and meet all requirements for national VA Pharmacy Benefits Management (PBM) Compounded Sterile Products Assessment guidelines.

1.5. The vendor must be able to provide documentation of compliance with the standards outlined in the current version of USP 797.

1.6. The vendor must provide any current or past survey or inspection results and responses from the Joint Commission, Board of Pharmacy, FDA, or any other governing body.

1.7. The vendor must be able to provide stability data for all medications upon request.

1.8. Medications shall not be delivered until ordered by the government.

1.9. Vendor shall notify the government of any anticipated shortages, recalls or discontinuation of the medications.

1.10. Vendor must be able to ensure and provide documentation that medications are handled appropriately per the manufacturer’s specifications prior to the receipt of the medication by VA Long Beach.

1.11. Medications must meet technical specifications stated in the FDA approved package.

1.12. Medication must be stored and used in according with directions on the labeling. If deviating from the FDA approved package insert, vendor must submit supporting evidence of practice and must be approved by the government before implementing.

**All Orders are based as needed basis**

The period of performance is October 1, 2022 through September 30, 2023.

Generic Name Brand Name Abatacept Orencia 125mg 4/box Abatacept Orencia 250mg Abatacept Orencia Click-Jet 125mg 4/box Abobotulinumtoxin A Dysport 500u Adalimumab Humira 40mg/0.8ml Pen 2/box Ado-trastuzumab emtansine Kadcyla 100mg/15ml Ado-trastuzumab emtansine Kadcyla 160mg/20ml Aflibercept Eylea 2mg Alteplase Cathflo Activase 2mg Amifostine Amifostine 500mg via-l 3/bx Amikacin Amikacin Sulfate PF 500mg/2ml 10/box Amphotericin B Amphotericin B 50mg Arginine R-Gene HCL 300ml Aripiprazole Ability Maintena 400mg Syringe Arsenic Trisenox 10mg 10/box Arsenic Trisenox 12mg 10/box Asparaginase Erwinia Erwinaze 10,000iu/vi - Svl/box Atezoliumab Tecentriq 60mg/ml 20ml Atropine Atropine 0.4mg/ml 25/box Atropine Atropine 1mg syringe 10/box Atropine Atropine lmg/ml 25/box Avelumab Bavencio 20mg/ml 10ml Azacitidine Azacitidine 100mg Bacteriostatic Water Bacteriostatic Water 30ml 25/box BCG LIVE TICE BCG 50mg Belimumab Benlysta 120mg Belimumab Benlysta 400mg Bendamustine Belrapzo (Eagle brand) 100mg Bendamustine Bendeka 100mg

Generic Name Brand Name Bendamustine Treanda 100mg PWD Bendamustine Treanda 25mg PWD Benralizumab Fasenra 30mg Syr Bevacizumab Avastin 100mg Bevacizumab Avastin 400mg Bevacizumab-AWWB Mvasi 100mg Bevacizumab-AWWB Mvasi 400mg Bevacizumab-BVZR Zirabev 100mg Bevacizumab-BVZR Zirabev 400mg Bezlotoxumab Zinplava 1000mg Bleomycin Bleomycin 15u Blinatumomab Blincyto 35mcg Bortezomib Velcade 3.5mg Brentuximab Vedotin Adcetris 50mg Cabazitaxel Jevtana 60mg Calcium Gluconate Calcium Gluc 100mg 10% 10ml 25/box Calcium Gluconate Calcium Gluconate 10% 50ml 25/box Carboplatin Carboplatin 150mg Carboplatin Carboplatin 450mg Carboplatin Carboplatin 50mg Carboplatin Carboplatin 600mg Carfilzomib Kyprolis 30mg Carfilzomib Kyprolis 60mg Carmustine BicNu 100mg Carmustine in Polifeprosan Gliadel Wafer Cefazolin Cefazolin 1gm 25/box Cefepime Cefepime 1gm 10/box Ceftazidime Ceftazidime 2gm 10/box Ceftazidime Tazicef 1gm 25/box Ceftriaxone Ceftriaxone 1 gm 10/box Certolizumab Cimzia 200mg Syr 2/box Cetuximab Erbitux 100mg Cidofovir Cidofovir Cisplatin Cisplatin 100mg Cisplatin Cisplatin 50mg Cladribine Cladribine 10mg Clindamycin Clindamycin 300mg/50ml ea.

Clindamycin Clindamycin 600mg/4ml ea.

Clofarabine Clolar 20mg Collagenase Clostridium Hist Xiaflex 0.9mg vial Cyanocobalamin Cyanocobalamin 1000mcg/1ml 25/box Cyclophosphamide Cyclophosphamide 1gm Cyclophosphamide Cyclophosphamide 1gm Cyclophosphamide Cyclophosphamide 25mg (100 tabs)

Generic Name Brand Name Cyclophosphamide Cyclophosphamide 2gm Cyclophosphamide Cyclophosphamide 500mg Cyclophosphamide Cyclophosphamide 50mg (100 tabs) Cyclosporine Cyclosporine 250mg/5ml 10/box Cytarabine Cytarabine 100mg 5/box Cytarabine Cytarabine 2gm Cytarabine Liposomal Depocyt 50mg Dacarbazine Dacarbazine 200mg 10/box Dactinomycin Cosmegen 0.5mg Daratumumab Darzalex 100MG Daratumumab Darzalex 400MG Daunorubicin Daunorubicin 20mg/4mL 10/box Decitabine Dacogen 50mg Deferoxamine Deferoxamine 500mg 4/box Degarelix Firmagon 240mg (2 x120) Degarelix Firmagon 80mg Denosumab Prolia 60mg Denosumab Xgeva 120mg Dexamethasone Dexamethasone 10mg/mL 10mL 10/box Dexamethasone Dexamethasone 10mg/ml 1ml 25/box Dexamethasone Dexamethasone 4mg/ml 1ml 25/box

Dexamethasone Ozurdex Implant 0.7mg Kit (DS item 1-2 days)

Dexrazoxane Zinecard (Dexrazoxane) 500mg Diphenhydramine Diphenhydramine 50mg 25/box Docetaxel Docetaxel 160mg/8ml (20mg/ml) Docetaxel Docetaxel 20mg/2ml (10mg/mL) Docetaxel Docetaxel 80mg/8ml (10mg/mL) Doxorubicin Adriamycin 50mg Doxorubicin Doxorubicin 10mg 10/box Doxorubicin Doxorubicin 20mg Doxorubicin Doxorubicin 50mg Doxorubicin Doxorubicin 50mg Durvalumab Imfinzi 120mg Durvalumab Imfinzi 500mg Eculizumab Soliris 300mg Enfortumab Vedotin EJFV Padcev 30mg Ep9etin Epogen 10k unit 10/box Epinepherine Epinepherine 1:1000 25/box Epinepherine Epinepherine 30mg vial Epirubicin Epirubicin 200mg Epirubicin Epirubicin 50mg Epoetin Epogen 20k unit 10/box Epoetin Epogen 4k unit 10/box

Generic Name Brand Name Epoetin Procrit 10k unit 6/box Epoetin Procrit 20k unit 4/box Epoetin Procrit 40k unit 4/box Epoetin Procrit 4k unit 6/box Epoetin Alfa EPBX Retacrit 10k unit 10/box Epoetin Alfa EPBX Retacrit 40k unit 4/box Eribulin Mesylate Halaven 1mg Ertapenem lnvanz 1gm 10/box Etanercept Enbrel Mini 50mg/0.98ml Cart Etoposide Etoposide 100mg Etoposide Etoposide 1gm Etoposide Etoposide 500mg Famotidine Famotidine 20mg 25/box FAM-Trastuzumab-Deruxtecn-nxkiFAM Enhertu 100mg pwd Ferric Carboxymaltose Injectafer 750mg Ferric Gluconate Ferric Gluconate 62.5mg 10/box Ferumoxytol Feraheme 510mg Filgrastim Neupogen 300mcg syringe 10/box Filgrastim Neupogen 480mcg syringe 10/box Filgrastim AAFI 480mcg/0.8ml Syr each Nivestym 480mcg/0.8ml Syr each Filgrastim-Sndz Zarxio 300mcg syringe ea.

Filgrastim-Sndz Zarxio 480mcg syringe ea.

Floxuradine Floxuradine 500mg Fludarabine Fludarabine 50mg Fluorouracil Fluorouracil 1gm 10/box Fluorouracil Fluorouracil 2.5gm Fluorouracil Fluorouracil 500mg 10/box Fluorouracil Fluorouracil 5gm Fosaprepitant Emend 150mg Foscarnet Sodium Foscavir Ggm 10/box Fulvestrant Faslodex 250mg 2/box Furosemide Furosemide 100mg vial 25/box Furosemide Furosemide 20mg 25/box Ganciclovir Ganciclovir 500mg (Cytovene) 25/box Gemcitabine Gemcitabine 1gm Gemcitabine Gemcitabine 1gm (100mg/ml 10ml) Gemcitabine Gemcitabine 200mg Gemcitabine Gemcitabine 200mg (100mg/ml 2ml) Gemcitabine Gemcitabine 2gm Gemtuzumab Ozogamicin Mylotarg 4.5mg Gentamicin Sulfate Gentamicin 80mg 25/box Golimumab Simponi Aria 12.5mg/ml 4ml Granisetron Granisetron Hydrochloride 1mg Granisetron Granisetron Hydrochloride 4mg

Generic Name Brand Name Heparin Sodium Heparin Sodium 1000u/ml 1ml 25/box Hyaluronate Sodium Euflexxa 1% 20mg/2ml (20mg) syringe 3x2ml Hyaluronate Sodium Gel-One 30mg/3ml Syringe Hyaluronate Sodium Gelsyn-3, 8.4mg/ml 2ml syringe Hyaluronate Sodium Hyalgan 20mg/2ml syringe Hyaluronate Sodium Monovisc 22mg/ml 4ml Syringe Hyaluronate Sodium Orthovisc 30mg/2ml Syringe Hyaluronate Sodium Supartz 25mg/2.5ml Syringe Hyaluronate Sodium Synvisc 16mg/2ml 3x2ml Syringe Hyaluronate Sodium Synvisc-One 48mg/6ml Syringe Hyaluronate Sodium Visco-3 10mg/ml 3x 2.5ml Syringe Hydrocortisone Solu-Cortef 100mg Idarubicin Idarubicin 10mg Idarubicin Idarubicin 20mg Idarubicin Idarubicin 5mg Ifosfamide Ifosfamide 1gm Immune Globulin IVIG Octagam 10% 10gm Immune Globulin IVIG Octagam 10% 20gm Immune Globulin IVIG Octagam 10% 2gm Immune Globulin IVIG Octagam 10% 5gm Incobotulinumtoxin A Xeomin PR 200u PF Infliximab Remicade 100mg Infliximab-ABDA Renflexis 100mg Infliximab-DYYB lnflectra 100mg Interferon alfa 2-b lntron A l0mu Iohexal Omnipaque 300mg/50ml 10/box Iopamidol lsovue-300mg 61% 10x30ml Ipilimumab Yervoy 200mg Ipilimumab Yervoy 50mg Irinotecan Irinotecan 100mg Irinotecan Irinotecan 40mg Iron Dextran Infed 100mg 10/box Iron Sucrose Venofer 100mg 10/box Iron Sucrose Venofer 200mg 5/box IVIG ·Gamma gard 1gm vial IVIG Atgam S0mg/ml SxSml amp IVIG Carimune 12gm IVIG Carimune 6gm IVIG Gammagard 20gm vial IVIG Gammagard 5gm vial IVIG Gammagard 10gm vial IVIG Gammaked 10gm IVIG Gammaked 1gm IVIG Gammaked 2.5gm

Generic Name Brand Name IVIG Gammaked 20gm IVIG Gammaked 5gm LC BEADS 100-300um 2ml LC BEADS 300-500um 2ml LC BEADS 70-150um 2ml Leucovorin Leucovorin 100mg Leucovorin Leucovorin 350mg Leuprolide Acetate Eligard 22.5mg Leuprolide Acetate Eligard 30mg Leuprolide Acetate Eligard 45mg Leuprolide Acetate Eligard 7.5mg Leuprolide Acetate Leuprolide 14mg 2.8ml 14 day kit Leuprolide Acetate Lupron Depot 11.25mg Leuprolide Acetate Lupron Depot 3.75mg Levoleucovorin Fusilev 50mg Lidocaine Lidocaine 4% 40mg/ml 25x5ml Liposomal Doxorubicin Liposomal Doxorubicin 20mg Liposomal Doxorubicin Liposomal Doxorubicin 50mg Liposomal Irinotecan Onivyde 4.3mg/ml 10ml Lorazepam Lorazepam 2mg/1mL 10/box Lurbinectedin Zepzelca 4mg Magnesium Sulfate Magnesium Sulfate 1gm/2mL 25/box Mannitol Mannitol 25% 50mL each 25/box Mechlorethamine Mechlorethamine 10mg 4/box Melphalan Alkeran 50mg Mepolizumab Nucala 100mg Mesna Mesna 1gm Methotrexate Methotrexate 50mg PF 10/box Methotrexate Methotrexate PF 1gm Methotrexate Methotrexate PF 250mg 10ml Methylene Blue Provayblue 0.5% Sx10ml Methylprednisolone Solu-Medrol (A-Methapred) 125mg 25/box

Methylprednisolone Solu-Medrol (Methylprednisolone 40mg) x25

Metoclopramide Metoclopramide 10mg 25/box Mitomycin Mitomycin 20mg Mitomycin Mitomycin 40mg Mitomycin Mitomycin 5mg Mitoxantrone Novantrone 20mg Mitoxantrone Novantrone 25mg Mycophenolate Mofetil Cellcept 500mg 4x20ml Naltrexone Vivitrol 380mg Natalizumab Tysabri 300mg Nelarabine Arranon SF 250mg 6/box

Generic Name Brand Name Nivolumab Opdivo 100mg/10ml SDPF Nivolumab Opdivo 240mg/10ml SDPF Nivolumab Opdivo 40mg/4ml SDPF Normal Saline 0.9% NACL 50ml 25/box Obinutuzumab Gazyva 1000mg/40ml SDV PF Ocrelizumab Ocrevus 300mg Octreotide Octreotide 100mcg 10/box Octreotide Sandostatin LAR 10mg Octreotide Sandostatin LAR 20mg Octreotide Sandostatin LAR 30mg Ofatumumab Arzerra 20mg/ml 3x5ml ' Ofatumumab Arzerra 20mg/ml lxS0ml Omalizumab Xolair 150mg Syringe Omalizumab Xolair 75mg Syringe Onabotulinumtoxina Botox 100iu (drop ship - dr info req) Oncozene Beads 100mcm Ondansetron Ondansetron 40mg Ondansetron Ondansetron 4mg 25/box Oxaliplatin Oxaliplatin 100mg Oxaliplatin Oxaliplatin 50mg Paclitaxel Paclitaxel 100mg Paclitaxel Paclitaxel 300mg Paclitaxel Paclitaxel 30mg Palifermin Kepivance 6.25mg/ml 3/box Palonosetron Palonosetron 0.25mg Pamidronate Pamidronate 30mg Pamidronate Pamidronate 90mg Panitumumab Vectibix 100 Panitumumab Vectibix 400 PB Paclitaxel Abraxane 100mg Pegasparaginase Oncaspar 3,750 units Pegfilgrastim Fulphila 6mg/0.6ml syringe Pegfilgrastim Neulasta 6mg syringe Pegfilgrastim Neulasta Onpro Delivery Kit 6mg Pegfilgrastim Udenyca 6mg/0.6ml syringe Pembrolizumab Keytruda 100mg Pembrolizumab Keytruda 100mg x2 Pemetrexed Alimta 100mg Pemetrexed Alimta 500mg Pentamidine Isethionate Pentam 300mg 10/box Pentamidine lsethionate Nebupent 300mg Pentostatin Nipent 10mg Pertuzumab Perjeta 420mg Polatuzumab Vedotin-PIIQ Polivy 30mg

Generic Name Brand Name Potassium Potassium Chloride 20meq 25/box Pralatrexate Folotyn 20mg Pralatrexate Folotyn 40mg Prochlorperazine Prochlorperazine Edisylate 10mg 10/box Promethazine Promethazine 25mg 25/box Ramucirumab Cyramza 100mg Ramucirumab Cyramza 500mg Ranibizumab Lucentis .3mg/.05ml vial Ranibizumab Lucentis .5mg/.0SmL vial Ranitidine Ranitidine 50mg/2ml 10/box Rasburicase Elitek 1.5mg 3/box Rasburicase Elitek 7.5mg vial Rimabotulinumtoxinb Myobloc 5000u/ml 1ml Risankizumab-RZAA Skyrizi 75mg/0.83ml Rituximab Rituxan 100mg Rituximab Rituxan 500mg Rituximab-ABBS Truxima 100mg Rituximab-ABBS Truxima 500mg Rituximab-PVVR Ruxience 100mg Rituximab-PVVR Ruxience 500mg Romidepsin lstodax 10mg Romiplostim Nplate 250mcg Romiplostim Nplate 500mcg Sodium Bicarbonate Sodium Bicarbonate 8.4% 50ml syr 10/box

Sodium Bicarbonate Sodium Bicarbonate 8.4% 50meq vial 25/box

Tacrolimus Prograf 5mg/ml 1ml PF Amp 10/box Tbo-Filgrastim Granix 300mcg Syringe x1 Tbo-Filgrastim Granix 480 mcg Syringe x1 Temsirolimus Torisel 25mg Testosterone Depo-Testosterone 200mg/10ml Tetracaine Tetracaine .5% OPHT Sol 12/box Thiotepa Thiotepa 15mg Thyrotropin Thyrogen 1.1mg x2 Tocilizumab Actemra 200mg Tocilizumab Actemra 400mg Tocilizumab Actemra 80mg Topotecan Topotecan 4mg Trabectedin Yondelis 1mg Trastuzumab Herceptin 150mg Trastuzumab-ANNS Kanjinti 150mg Trastuzumab-ANNS· Kanjinti 420mg Trastuzumab-QYYP Trazimera 420mg Triamcinalone PF Triesence 40mg/1ml PF Triptorelin Trelstar 3.75mg

Generic Name Brand Name Ustekinumab Sterlara 130mg Smg/ml 26ml Valrubicin Valstar 40mg/ml 5ml SDV 4/box Vancomycin Vancomycin 1gm 10/box Vedolizumab Entyvio 300mg 20ml SDV Vinblastine Vinblastine 10mg Vincristine Vincristine 1mg Vincristine Vincristine 2mg Vinorelbine Vinorelbine 10mg Vinorelbine Vinorelbine 50mg Water Sterile Water 10ml 25/box Water Sterile Water 50ml 25/box Ziv-Afilbercept Zaltrap 100mg Ziv-Afilbercept Zaltrap 200mg Zoledronic Acid Zoledronic Acid 4mg/5ml (Generic Zometa) Zoledronic Acid Zoledronic Acid 5mg (Generic Reclast)

**NOTICE: Remanufactures or gray market items/ supplies will not be acceptable.

Interested parties of RFI/RFQ must be an authorized and licensed drug distributor.

Verification can be provided by an authorization letter and via Verify Wholesale Drug Distributor Licenses | FDA. Medication shall be in accordance with the manufacturer’s terms and conditions. No exceptions. Must be a manufacturer authorized distributor.

Delivery: Upon completion of compounding, medications will be transported VIA FedEx to VA prior to Chemotherapy Infusion Date. Must be able to provide next day delivery.

(See Statement of Work for instructions)

Place of Performance/Place of Delivery:

Department of Veterans Affairs VHA Long Beach Healthcare System 5901 East 7th Street Long Beach, CA 90822

B.3 PRICE/COST SCHEDULE

ITEM INFORMATION

ITEM

NUMBER

DESCRIPTION OF

SUPPLIES/SERVICES QUANTITY UNIT UNIT PRICE AMOUNT

0001 1.00 YR ______________ _____________

Estimated Cost of Compounded Chemotherapy (cost per week including *special fees*)

0002 1.00 YR _____________ _____________

Estimated Shipping Fees (cost per week)

0003 1.00 YR _____________ _____________

Per Patient Order Fees

GRAND TOTAL _____________

B.4 DELIVERY SCHEDULE

ITEM NUMBER QUANTITY

DELIVERY

DATE

0001 1.00 10/1/22-9/30/23

0002 1.00 10/1/22-9/30/23

0003 1.00 10/1/22-9/30/23

SECTION C - CONTRACT CLAUSES

FAR

Number

Title Date

52.203-17 CONTRACTOR EMPLOYEE WHISTLEBLOWER RIGHTS

AND REQUIREMENT TO INFORM EMPLOYEES OF

WHISTLEBLOWER RIGHTS

JUN 2020

52.204-13 SYSTEM FOR AWARD MANAGEMENT MAINTENANCE OCT 2018

52.204-18 COMMERCIAL AND GOVERNMENT ENTITY CODE

MAINTENANCE

AUG 2020

52.204-4 PRINTED OR COPIED DOUBLE-SIDED ON

POSTCONSUMER FIBER CONTENT PAPER

MAY 2011

C.1 52.212-4 CONTRACT TERMS AND CONDITIONS—COMMERCIAL

PRODUCTS AND COMMERCIAL SERVICES (NOV 2021)

(a) Inspection/Acceptance. The Contractor shall only tender for acceptance those items that conform to the requirements of this contract. The Government reserves the right to inspect or test any supplies or services that have been tendered for acceptance. The Government may require repair or replacement of nonconforming supplies or reperformance of nonconforming services at no increase in contract price. If repair/replacement or reperformance will not correct the defects or is not possible, the Government may seek an equitable price reduction or adequate consideration for acceptance of nonconforming supplies or services. The Government must exercise its post-acceptance rights—

(1) Within a reasonable time after the defect was discovered or should have been discovered;

and

(2) Before any substantial change occurs in the condition of the item, unless the change is due to the defect in the item.

(b) Assignment. The Contractor or its assignee may assign its rights to receive payment due as a result of performance of this contract to a bank, trust company, or other financing institution, including any Federal lending agency in accordance with the Assignment of Claims Act (31 U.S.C. 3727). However, when a third party makes payment (e.g., use of the Governmentwide commercial purchase card), the Contractor may not assign its rights to receive payment under this contract.

(c) Changes. Changes in the terms and conditions of this contract may be made only by written agreement of the parties.

(d) Disputes. This contract is subject to 41 U.S.C. chapter 71, Contract Disputes. Failure of the parties to this contract to reach agreement on any request for equitable adjustment, claim, appeal or action arising under or relating to this contract shall be a dispute to be resolved in accordance with the clause at Federal Acquisition Regulation (FAR) 52.233-1, Disputes, which is incorporated herein by reference. The Contractor shall proceed diligently with performance of this contract, pending final resolution of any dispute arising under the contract.

(e) Definitions. The clause at FAR 52.202-1, Definitions, is incorporated herein by reference.

(f) Excusable delays. The Contractor shall be liable for default unless nonperformance is caused by an occurrence beyond the reasonable control of the Contractor and without its fault or negligence such as, acts of God or the public enemy, acts of the Government in either its sovereign or contractual capacity, fires, floods, epidemics, quarantine restrictions, strikes, unusually severe weather, and delays of common carriers. The Contractor shall notify the Contracting Officer in writing as soon as it is reasonably possible after the commencement of any excusable delay, setting forth the full particulars in connection therewith, shall remedy such occurrence with all reasonable dispatch, and shall promptly give written notice to the Contracting Officer of the cessation of such occurrence.

(g) Invoice.

(1) The Contractor shall submit an original invoice and three copies (or electronic invoice, if authorized) to the address designated in the contract to receive invoices. An invoice must include—

(i) Name and address of the Contractor;

(ii) Invoice date and number;

(iii) Contract number, line item number and, if applicable, the order number;

(iv) Description, quantity, unit of measure, unit price and extended price of the items delivered;

(v) Shipping number and date of shipment, including the bill of lading number and weight of shipment if shipped on Government bill of lading;

(vi) Terms of any discount for prompt payment offered;

(vii) Name and address of official to whom payment is to be sent;

(viii) Name, title, and phone number of person to notify in event of defective invoice; and

(ix) Taxpayer Identification Number (TIN). The Contractor shall include its TIN on the invoice only if required elsewhere in this contract.

(x) Electronic funds transfer (EFT) banking information.

(A) The Contractor shall include EFT banking information on the invoice only if required elsewhere in this contract.

(B) If EFT banking information is not required to be on the invoice, in order for the invoice to be a proper invoice, the Contractor shall have submitted correct EFT banking information in accordance with the applicable solicitation provision, contract clause (e.g., 52.232-33, Payment by Electronic Funds Transfer—System for Award Management, or 52.232-34, Payment by Electronic Funds Transfer—Other Than System for Award Management), or applicable agency procedures.

(C) EFT banking information is not required if the Government waived the requirement to pay by EFT.

(2) Invoices will be handled in accordance with the Prompt Payment Act (31 U.S.C. 3903) and Office of Management and Budget (OMB) prompt payment regulations at 5 CFR part 1315.

(h) Patent indemnity. The Contractor shall indemnify the Government and its officers, employees and agents against liability, including costs, for actual or alleged direct or contributory infringement of, or inducement to infringe, any United States or foreign patent, trademark or copyright, arising out of the performance of this contract, provided the Contractor is reasonably notified of such claims and proceedings.

(i) Payment.—

(1) Items accepted. Payment shall be made for items accepted by the Government that have been delivered to the delivery destinations set forth in this contract.

(2) Prompt payment. The Government will make payment in accordance with the Prompt Payment Act (31 U.S.C. 3903) and prompt payment regulations at 5 CFR part 1315.

(3) Electronic Funds Transfer (EFT). If the Government makes payment by EFT, see 52.212- 5(b) for the appropriate EFT clause.

(4) Discount. In connection with any discount offered for early payment, time shall be computed from the date of the invoice. For the purpose of computing the discount earned, payment shall be considered to have been made on the date which appears on the payment check or the specified payment date if an electronic funds transfer payment is made.

(5) Overpayments. If the Contractor becomes aware of a duplicate contract financing or invoice payment or that the Government has otherwise overpaid on a contract financing or invoice payment, the Contractor shall—

(i) Remit the overpayment amount to the payment office cited in the contract along with a description of the overpayment including the—

(A) Circumstances of the overpayment (e.g., duplicate payment, erroneous payment, liquidation errors, date(s) of overpayment);

(B) Affected contract number and delivery order number, if applicable;

(C) Affected line item or subline item, if applicable; and

(D) Contractor point of contact.

(ii) Provide a copy of the remittance and supporting documentation to the Contracting Officer.

(6) Interest.

(i) All amounts that become payable by the Contractor to the Government under this contract shall bear simple interest from the date due until paid unless paid within 30 days of becoming due. The interest rate shall be the interest rate established by the Secretary of the Treasury as provided in 41 U.S.C. 7109, which is applicable to the period in which the amount becomes due, as provided in (i)(6)(v) of this clause, and then at the rate applicable for each six-month period as fixed by the Secretary until the amount is paid.

(ii) The Government may issue a demand for payment to the Contractor upon finding a debt is due under the contract.

(iii) Final decisions. The Contracting Officer will issue a final decision as required by 33.211 if—

(A) The Contracting Officer and the Contractor are unable to reach agreement on the existence or amount of a debt within 30 days;

(B) The Contractor fails to liquidate a debt previously demanded by the Contracting Officer within the timeline specified in the demand for payment unless the amounts were not repaid because the Contractor has requested an installment payment agreement; or

(C) The Contractor requests a deferment of collection on a debt previously demanded by the Contracting Officer (see 32.607-2).

(iv) If a demand for payment was previously issued for the debt, the demand for payment included in the final decision shall identify the same due date as the original demand for payment.

(v) Amounts shall be due at the earliest of the following dates:

(A) The date fixed under this contract.

(B) The date of the first written demand for payment, including any demand for payment resulting from a default termination.

(vi) The interest charge shall be computed for the actual number of calendar days involved beginning on the due date and ending on—

(A) The date on which the designated office receives payment from the Contractor;

(B) The date of issuance of a Government check to the Contractor from which an amount otherwise payable has been withheld as a credit against the contract debt; or

(C) The date on which an amount withheld and applied to the contract debt would otherwise have become payable to the Contractor.

(vii) The interest charge made under this clause may be reduced under the procedures prescribed in FAR 32.608-2 in effect on the date of this contract.

(j) Risk of loss. Unless the contract specifically provides otherwise, risk of loss or damage to the supplies provided under this contract shall remain with the Contractor until, and shall pass to the Government upon:

(1) Delivery of the supplies to a carrier, if transportation is f.o.b. origin; or

(2) Delivery of the supplies to the Government at the destination specified in the contract, if transportation is f.o.b. destination.

(k) Taxes. The contract price includes all applicable Federal, State, and local taxes and duties.

(l) Termination for the Government's convenience. The Government reserves the right to terminate this contract, or any part hereof, for its sole convenience. In the event of such termination, the Contractor shall immediately stop all work hereunder and shall immediately cause any and all of its suppliers and subcontractors to cease work. Subject to the terms of this contract, the Contractor shall be paid a percentage of the contract price reflecting the percentage of the work performed prior to the notice of termination, plus reasonable charges the Contractor can demonstrate to the satisfaction of the Government using its standard record keeping system, have resulted from the termination. The Contractor shall not be required to comply with the cost accounting standards or contract cost principles for this purpose. This paragraph does not give the Government any right to audit the Contractor's records. The Contractor shall not be paid for any work performed or costs incurred which reasonably could have been avoided.

(m) Termination for cause. The Government may terminate this contract, or any part hereof, for cause in the event of any default by the Contractor, or if the Contractor fails to comply with any contract terms and conditions, or fails to provide the Government, upon request, with adequate assurances of future performance. In the event of termination for cause, the Government shall not be liable to the Contractor for any amount for supplies or services not accepted, and the Contractor shall be liable to the Government for any and all rights and remedies provided by law. If it is determined that the Government improperly terminated this contract for default, such termination shall be deemed a termination for convenience.

(n) Title. Unless specified elsewhere in this contract, title to items furnished under this contract shall pass to the Government upon acceptance, regardless of when or where the Government takes physical possession.

(o) Warranty. The Contractor warrants and implies that the items delivered hereunder are merchantable and fit for use for the particular purpose described in this contract.

(p) Limitation of liability. Except as otherwise provided by an express warranty, the Contractor will not be liable to the Government for consequential damages resulting from any defect or deficiencies in accepted items.

(q) Other compliances. The Contractor shall comply with all applicable Federal, State and local laws, executive orders, rules and regulations applicable to its performance under this contract.

(r) Compliance with laws unique to Government contracts. The Contractor agrees to comply with 31 U.S.C. 1352 relating to limitations on the use of appropriated funds to influence certain Federal contracts; 18 U.S.C. 431 relating to officials not to benefit; 40 U.S.C. chapter 37, Contract Work Hours and Safety Standards; 41 U.S.C. chapter 87, Kickbacks; 41 U.S.C. 4712 and 10 U.S.C. 2409 relating to whistleblower protections; 49 U.S.C. 40118, Fly American; and 41 U.S.C. chapter 21 relating to procurement integrity.

(s) Order of precedence. Any inconsistencies in this solicitation or contract shall be resolved by giving precedence in the following order:

(1) The schedule of supplies/services.

(2) The Assignments, Disputes, Payments, Invoice, Other Compliances, Compliance with Laws Unique to Government Contracts, and Unauthorized Obligations paragraphs of this clause;

(3) The clause at 52.212-5.

(4) Addenda to this solicitation or contract, including any license agreements for computer software.

(5) Solicitation provisions if this is a solicitation.

(6) Other paragraphs of this clause.

(7) The Standard Form 1449.

(8) Other documents, exhibits, and attachments

(9) The specification.

(t) [Reserved]

(u) Unauthorized Obligations.

(1) Except as stated in paragraph (u)(2) of this clause, when any supply or service acquired under this contract is subject to any End User License Agreement (EULA), Terms of Service (TOS), or similar legal instrument or agreement, that includes any clause requiring the Government to indemnify the Contractor or any person or entity for damages, costs, fees, or any other loss or liability that would create an Anti-Deficiency Act violation (31 U.S.C. 1341), the following shall govern:

(i) Any such clause is unenforceable against the Government.

(ii) Neither the Government nor any Government authorized end user shall be deemed to have agreed to such clause by virtue of it appearing in the EULA, TOS, or similar legal instrument or agreement. If the EULA, TOS, or similar legal instrument or agreement is invoked through an “I agree” click box or other comparable mechanism (e.g., “click-wrap” or “browse-wrap” agreements), execution does not bind the Government or any Government authorized end user to such clause.

(iii) Any such clause is deemed to be stricken from the EULA, TOS, or similar legal instrument or agreement.

(2) Paragraph (u)(1) of this clause does not apply to indemnification by the Government that is expressly authorized by statute and specifically authorized under applicable agency regulations and procedures.

(v) Incorporation by reference. The Contractor’s representations and certifications, including those completed electronically via the System for Award Management (SAM), are incorporated by reference into the contract.

(End of Clause)

ADDENDUM to FAR 52.212-4 CONTRACT TERMS AND CONDITIONS—COMMERCIAL

PRODUCTS AND COMMERCIAL SERVICES

Clauses that are incorporated by reference (by Citation Number, Title, and Date), have the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available.

The following clauses are incorporated into 52.212-4 as an addendum to this contract:

(End of Addendum to 52.212-4)

C.2 52.212-5 CONTRACT TERMS AND CONDITIONS REQUIRED TO

IMPLEMENT STATUTES OR EXECUTIVE ORDERS—COMMERCIAL

PRODUCTS AND COMMERCIAL SERVICES (MAY 2022) (JUL 2020)

(DEVIATION)

(a) The Contractor shall comply with the following Federal Acquisition Regulation (FAR) clauses, which are incorporated in this contract by reference, to implement provisions of law or Executive orders applicable to acquisitions of commercial products and commercial services:

(1) 52.203-19, Prohibition on Requiring Certain Internal Confidentiality Agreements or Statements (JAN 2017) (section 743 of Division E, Title VII, of the Consolidated and Further Continuing Appropriations Act, 2015 (Pub. L. 113-235) and its successor provisions in subsequent appropriations acts (and as extended in continuing resolutions)).

(2) 52.204–23, Prohibition on Contracting for Hardware, Software, and Services Developed or Provided by Kaspersky Lab and Other Covered Entities (NOV 2021) (Section 1634 of Pub. L.

115–91).

(3) 52.204–25, Prohibition on Contracting for Certain Telecommunications and Video Surveillance Services or Equipment. (NOV 2021) (Section 889(a)(1)(A) of Pub. L. 115–232).

(4) 52.209-10, Prohibition on Contracting with Inverted Domestic Corporations (NOV 2015).

(5) 52.233-3, Protest After Award (Aug 1996) (31 U.S.C. 3553).

(6) 52.233-4, Applicable Law for Breach of Contract Claim (Oct 2004) (Public Laws 108-77 and 108-78 (19 U.S.C. 3805 note)).

(b) The Contractor shall comply with the FAR clauses in this paragraph (b) that the Contracting Officer has indicated as being incorporated in this contract by reference to implement provisions of law or Executive orders applicable to acquisitions of commercial products and commercial services:

[X] (1) 52.203–6, Restrictions on Subcontractor Sales to the Government (JUN 2020), with Alternate I (NOV 2021) (41 U.S.C. 4704 and 10 U.S.C. 2402).

[] (2) 52.203–13, Contractor Code of Business Ethics and Conduct (NOV 2021) (41 U.S.C.

3509).

[] (3) 52.203–15, Whistleblower Protections under the American Recovery and Reinvestment Act of 2009 (JUN 2010) (Section 1553 of Pub. L. 111-5). (Applies to contracts funded by the American Recovery and Reinvestment Act of 2009.)

[X] (4) 52.204–10, Reporting Executive Compensation and First-Tier Subcontract Awards (JUN 2020) (Pub. L. 109–282) (31 U.S.C. 6101 note).

[] (5) [Reserved]

[] (6) 52.204–14, Service Contract Reporting Requirements (OCT 2016) (Pub. L. 111–117, section 743 of Div. C).

[] (7) 52.204–15, Service Contract Reporting Requirements for Indefinite-Delivery Contracts (OCT 2016) (Pub. L. 111–117, section 743 of Div. C).

[X] (8) 52.209–6, Protecting the Government’s Interest When Subcontracting with Contractors Debarred, Suspended, or Proposed for Debarment. (NOV 2021) (31 U.S.C. 6101 note).

[X] (9) 52.209-9, Updates of Publicly Available Information Regarding Responsibility Matters (Oct 2018) (41 U.S.C. 2313).

[] (10) [Reserved]

[] (11) 52.219–3, Notice of HUBZone Set-Aside or Sole-Source Award (SEP 2021) (15 U.S.C. 657a).

[X] (12) 52.219–4, Notice of Price Evaluation Preference for HUBZone Small Business Concerns (SEP 2021) (if the offeror elects to waive the preference, it shall so indicate in its offer) (15 U.S.C. 657a).

[] (13) [Reserved]

[] (14)(i) 52.219-6, Notice of Total Small Business Set-Aside (NOV 2020) (15 U.S.C. 644).

[] (ii) Alternate I (MAR 2020) of 52.219-6.

[] (15)(i) 52.219-7, Notice of Partial Small Business Set-Aside (NOV 2020) (15 U.S.C. 644).

[] (ii) Alternate I (MAR 2020) of 52.219-7.

[X] (16) 52.219-8, Utilization of Small Business Concerns (Oct 2018) (15 U.S.C. 637(d)(2) and (3)).

[] (17)(i) 52.219–9, Small Business Subcontracting Plan (NOV 2021) (15 U.S.C. 637(d)(4)).

[] (ii) Alternate I (NOV 2016) of 52.219-9.

[] (iii) Alternate II (NOV 2016) of 52.219-9.

[] (iv) Alternate III (JUN 2020) of 52.219–9.

[] (v) Alternate IV (SEP 2021) of 52.219–9.

[] (18)(i) 52.219-13, Notice of Set-Aside of Orders (MAR 2020) (15 U.S.C. 644(r)).

[] (ii) Alternate I (MAR 2020) of 52.219-13.

[] (19) 52.219–14, Limitations on Subcontracting (SEP 2021) (15 U.S.C. 657s).

[] (20) 52.219-16, Liquidated Damages—Subcontracting Plan (SEP 2021) (15 U.S.C.

637(d)(4)(F)(i)).

[] (21) 52.219–27, Notice of Service-Disabled Veteran-Owned Small Business Set-Aside (SEP 2021) (15 U.S.C. 657f).

[X] (22) (i) 52.219–28, Post-Award Small Business Program Rerepresentation (SEP 2021) (15 U.S.C. 632(a)(2)).

[] (ii) Alternate I (MAR 2020) of 52.219–28.

[] (23) 52.219–29, Notice of Set-Aside for, or Sole-Source Award to, Economically Disadvantaged Women-Owned Small Business Concerns (SEP 2021) (15 U.S.C. 637(m)).

[] (24) 52.219–30, Notice of Set-Aside for, or Sole-Source Award to, Women-Owned Small Business Concerns Eligible Under the Women-Owned Small Business Program (SEP 2021) (15 U.S.C. 637(m)).

[] (25) 52.219-32, Orders Issued Directly Under Small Business Reserves (MAR 2020) (15 U.S.C. 644(r)).

[] (26) l(26) 52.219–33, Nonmanufacturer Rule (SEP 2021) (15 U.S.C. 657s).

[] (27) 52.222-3, Convict Labor (June 2003) (E.O. 11755).

[X] (28) 52.222–19, Child Labor—Cooperation with Authorities and Remedies (JUL 2020)

(DEVIATION) (E.O. 13126).

[X] (29) 52.222-21, Prohibition of Segregated Facilities (APR 2015).

[X] (30)(i) 52.222–26, Equal Opportunity (SEP 2016) (E.O. 11246).

[] (ii) Alternate I (FEB 1999) of 52.222-26.

[X] (31)(i) 52.222–35, Equal Opportunity for Veterans (JUN 2020) (38 U.S.C. 4212).

[] (ii) Alternate I (JULY 2014) of 52.222-35.

[X] (32)(i) 52.222–36, Equal Opportunity for Workers with Disabilities (JUN 2020) (29 U.S.C.

793).

[] (ii) Alternate I (JULY 2014) of 52.222-36.

[X] (33) 52.222–37, Employment Reports on Veterans (JUN 2020) (38 U.S.C. 4212).

[X] (34) 52.222-40, Notification of Employee Rights Under the National Labor Relations Act

(DEC 2010) (E.O. 13496).

[X] (35)(i) 52.222-50, Combating Trafficking in Persons (NOV 2021) (22 U.S.C. chapter 78 and E.O. 13627).

[] (ii) Alternate I (MAR 2015) of 52.222-50 (22 U.S.C. chapter 78 and E.O. 13627).

[] (36) 52.222-54, Employment Eligibility Verification (MAY 2022). (E. O. 12989). (Not applicable to the acquisition of commercially available off-the-shelf items or certain other types of commercial products or commercial services as prescribed in FAR 22.1803.)

[] (37)(i) 52.223-9, Estimate of Percentage of Recovered Material Content for EPA- Designated Items (May 2008) (42 U.S.C.6962(c)(3)(A)(ii)). (Not applicable to the acquisition of commercially available off-the-shelf items.)

[] (ii) Alternate I (MAY 2008) of 52.223-9 (42 U.S.C. 6962(i)(2)(C)). (Not applicable to the acquisition of commercially available off-the-shelf items.)

[] (38) 52.223-11, Ozone-Depleting Substances and High Global Warming Potential Hydrofluorocarbons (JUN 2016) (E.O. 13693).

[] (39) 52.223-12, Maintenance, Service, Repair, or Disposal of Refrigeration Equipment and Air Conditioners (JUN 2016) (E.O. 13693).

[] (40)(i) 52.223-13, Acquisition of EPEAT®-Registered Imaging Equipment (JUN 2014) (E.O.s 13423 and 13514).

[] (ii) Alternate I (OCT 2015) of 52.223-13.

[] (41)(i) 52.223-14, Acquisition of EPEAT®-Registered Televisions (JUN 2014) (E.O.s 13423 and 13514).

[] (ii) Alternate I (JUN 2014) of 52.223-14.

[] (42) 52.223-15, Energy Efficiency in Energy-Consuming Products (MAY 2020) (42 U.S.C.

8259b).

[] (43)(i) 52.223-16, Acquisition of EPEAT®-Registered Personal Computer Products (OCT 2015) (E.O.s 13423 and 13514).

[] (ii) Alternate I (JUN 2014) of 52.223-16.

[X] (44) 52.223–18, Encouraging Contractor Policies to Ban Text Messaging While Driving

(JUN 2020) (E.O. 13513).

[] (45) 52.223-20, Aerosols (JUN 2016) (E.O. 13693).

[] (46) 52.223-21, Foams (JUN 2016) (E.O. 13693).

[] (47) (i) 52.224-3, Privacy Training (JAN 2017) (5 U.S.C. 552a).

[] (ii) Alternate I (JAN 2017) of 52.224-3.

[] (48) 52.225-1, Buy American—Supplies (NOV 2021) (41 U.S.C. chapter 83).

[] (49)(i) 52.225-3, Buy American—Free Trade Agreements—Israeli Trade Act (JUL 2020) (DEVIATION) (19 U.S.C. 3301 note, 19 U.S.C. 2112 note, 19 U.S.C. 3805 note, 19 U.S.C. 4001 note, 19 U.S.C chapter 29 (sections 4501-4732), Pub. L. 103-182, 108-77, 108-78, 108-286, 108-302, 109-53, 109-169, 109-283, 110-138, 112-41, 112-42, and 112-43.

[] (ii) Alternate II (JUL 2020) (DEVIATION) of 52.225-3.

[] (iii) Alternate III (JUL 2020) (DEVIATION) of 52.225-3.

[X] (50) 52.225–5, Trade Agreements (JUL 2020) (DEVIATION) (19 U.S.C. 2501, et seq., 19 U.S.C. 3301 note).

[X] (51) 52.225-13, Restrictions on Certain Foreign Purchases (FEB 2021) (E.O.'s, proclamations, and statutes administered by the Office of Foreign Assets Control of the Department of the Treasury).

[] (52) 52.225–26, Contractors Performing Private Security Functions Outside the United States (OCT 2016) (Section 862, as amended, of the National Defense Authorization Act for Fiscal Year 2008; 10 U.S.C. 2302 Note).

[] (53) 52.226-4, Notice of Disaster or Emergency Area Set-Aside (Nov 2007) (42 U.S.C.

5150).

[] (54) 52.226-5, Restrictions on Subcontracting Outside Disaster or Emergency Area (Nov 2007) (42 U.S.C. 5150).

[X] (55) 52.229–12, Tax on Certain Foreign Procurements (FEB 2021).

[] (56) 52.232-29, Terms for Financing of Purchases of Commercial Products and Commercial Services (NOV 2021) (41 U.S.C. 4505, 10 U.S.C. 2307(f)).

[] (57) 52.232-30, Installment Payments for Commercial Products and Commercial Services (NOV 2021) (41 U.S.C. 4505, 10 U.S.C. 2307(f)).

[X] (58) 52.232-33, Payment by Electronic Funds Transfer—System for Award Management (Oct 2018) (31 U.S.C. 3332).

[] (59) 52.232-34, Payment by Electronic Funds Transfer—Other than System for Award Management (Jul 2013) (31 U.S.C. 3332).

[] (60) 52.232-40, Providing Accelerated Payments to Small Business Subcontractors (DEC 2013) (DEVIATION AUG 2020) (31 U.S.C. 3903 and 10 U.S.C 2307).

[] (61) 52.239-1, Privacy or Security Safeguards (AUG 1996) (5 U.S.C. 552a).

[] (62) 52.242-5, Payments to Small Business Subcontractors (JAN 2017)(15 U.S.C.

637(d)(13)).

[] (63)(i) 52.247-64, Preference for Privately Owned U.S.-Flag Commercial Vessels (NOV 2021) (46 U.S.C. 55305 and 10 U.S.C. 2631).

[] (ii) Alternate I (Apr 2003) of 52.247-64.

[] (iii) Alternate II (NOV 2021) of 52.247-64.

(c) The Contractor shall comply with the FAR clauses in this paragraph (c), applicable to commercial services, that the Contracting Officer has indicated as being incorporated in this contract by reference to implement provisions of law or Executive orders applicable to acquisitions of commercial products and commercial services:

[] (1) 52.222-41, Service Contract Labor Standards (AUG 2018) (41 U.S.C. chapter 67).

[] (2) 52.222-42, Statement of Equivalent Rates for Federal Hires (MAY 2014) (29 U.S.C. 206 and 41 U.S.C. chapter 67).

[] (3) 52.222-43, Fair Labor Standards Act and Service Contract Labor Standards—Price Adjustment (Multiple Year and Option Contracts) (AUG 2018) (29 U.S.C. 206 and 41 U.S.C.

chapter 67).

[] (4) 52.222-44, Fair Labor Standards Act and Service Contract Labor Standards—Price Adjustment (MAY 2014) (29 U.S.C 206 and 41 U.S.C. chapter 67).

[] (5) 52.222-51, Exemption from Application of the Service Contract Labor Standards to Contracts for Maintenance, Calibration, or Repair of Certain Equipment—Requirements (MAY 2014) (41 U.S.C. chapter 67).

[] (6) 52.222-53, Exemption from Application of the Service Contract Labor Standards to Contracts for Certain…